The great escape: tumour cell plasticity in resistance to targeted therapy

S Boumahdi, FJ de Sauvage - Nature reviews Drug discovery, 2020 - nature.com
The success of targeted therapies in cancer treatment has been impeded by various
mechanisms of resistance. Besides the acquisition of resistance-conferring genetic …

Emerging role of tumor cell plasticity in modifying therapeutic response

S Qin, J Jiang, Y Lu, EC Nice, C Huang… - Signal transduction and …, 2020 - nature.com
Resistance to cancer therapy is a major barrier to cancer management. Conventional views
have proposed that acquisition of resistance may result from genetic mutations. However …

[HTML][HTML] Battling chemoresistance in cancer: root causes and strategies to uproot them

A Ramos, S Sadeghi, H Tabatabaeian - International journal of molecular …, 2021 - mdpi.com
With nearly 10 million deaths, cancer is the leading cause of mortality worldwide. Along with
major key parameters that control cancer treatment management, such as diagnosis …

Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance

H Lin, Y Wang, P Wang, F Long, T Wang - Molecular cancer, 2022 - Springer
The resistance of tumor cells to therapy severely impairs the efficacy of treatment, leading to
recurrence and metastasis of various cancers. Clarifying the underlying mechanisms of …

Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance

H Easwaran, HC Tsai, SB Baylin - Molecular cell, 2014 - cell.com
The existence of subpopulations of cells in cancers with increased tumor-initiating capacities
and self-renewal potential, often termed" cancer stem cells," is a much discussed and key …

Treatment-induced damage to the tumor microenvironment promotes prostate cancer therapy resistance through WNT16B

Y Sun, J Campisi, C Higano, TM Beer, P Porter… - Nature medicine, 2012 - nature.com
Acquired resistance to anticancer treatments is a substantial barrier to reducing the
morbidity and mortality that is attributable to malignant tumors. Components of tissue …

[HTML][HTML] A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

SV Sharma, DY Lee, B Li, MP Quinlan, F Takahashi… - Cell, 2010 - cell.com
Accumulating evidence implicates heterogeneity within cancer cell populations in the
response to stressful exposures, including drug treatments. While modeling the acute …

Cancer chemotherapy

DL Gustafson, RL Page - Withrow and MacEwen's small animal …, 2013 - books.google.com
The use of chemical elixirs for the treatment of cancer can be traced through the medicinal
customs and practices of a number of cultures. 1 The modern use of pharmacologic agents …

Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition

A Goldman, B Majumder, A Dhawan, S Ravi… - Nature …, 2015 - nature.com
Understanding the emerging models of adaptive resistance is key to overcoming cancer
chemotherapy failure. Using human breast cancer explants, in vitro cell lines, mouse in vivo …

[HTML][HTML] Multidrug resistance associated proteins in multidrug resistance

K Sodani, A Patel, RJ Kathawala… - Chinese journal of …, 2012 - ncbi.nlm.nih.gov
Multidrug resistance proteins (MRPs) are members of the C family of a group of proteins
named ATP-binding cassette (ABC) transporters. These ABC transporters together form the …